Baert F - Search Results

1

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.

Sandborn WJ, Baert F, Danese S, Krznarić Ž, Kobayashi T, Yao X, Chen J, Rosario M, Bhatia S, Kisfalvi K, D'Haens G, Vermeire S. Sandborn WJ, et al. Among authors: baert f. Gastroenterology. 2020 Feb;158(3):562-572.e12. doi: 10.1053/j.gastro.2019.08.027. Epub 2019 Aug 28. Gastroenterology. 2020. PMID: 31470005 Free article. Clinical Trial.

2

Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.

D'Haens G, Geboes K, Peeters M, Baert F, Ectors N, Rutgeerts P. D'Haens G, et al. Among authors: baert f. Am J Gastroenterol. 1997 Aug;92(8):1275-9. Am J Gastroenterol. 1997. PMID: 9260788

3

Clustering of increased small intestinal permeability in families with Crohn's disease.

Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, Baert F, Vermeire S, Vlietinck R, Rutgeerts P. Peeters M, et al. Among authors: baert f. Gastroenterology. 1997 Sep;113(3):802-7. doi: 10.1016/s0016-5085(97)70174-4. Gastroenterology. 1997. PMID: 9287971

4

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. D'Haens GR, et al. Among authors: baert f. Gastroenterology. 1998 Feb;114(2):262-7. doi: 10.1016/s0016-5085(98)70476-7. Gastroenterology. 1998. PMID: 9453485

5

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ. Baert FJ, et al. Gastroenterology. 1999 Jan;116(1):22-8. doi: 10.1016/s0016-5085(99)70224-6. Gastroenterology. 1999. PMID: 9869598 Clinical Trial.

6

Methotrexate in refractory Crohn's disease.

Vandeputte L, D'Haens G, Baert F, Rutgeerts P. Vandeputte L, et al. Among authors: baert f. Inflamm Bowel Dis. 1999 Feb;5(1):11-5. doi: 10.1097/00054725-199902000-00002. Inflamm Bowel Dis. 1999. PMID: 10028444

7

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

D'haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, Braakman T, Schaible T, Geboes K, Rutgeerts P. D'haens G, et al. Among authors: baert f. Gastroenterology. 1999 May;116(5):1029-34. doi: 10.1016/s0016-5085(99)70005-3. Gastroenterology. 1999. PMID: 10220494 Clinical Trial.

8

Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group.

Belaiche J, Louis E, D'Haens G, Cabooter M, Naegels S, De Vos M, Fontaine F, Schurmans P, Baert F, De Reuck M, Fiasse R, Holvoet J, Schmit A, Van Outryve M. Belaiche J, et al. Among authors: baert f. Am J Gastroenterol. 1999 Aug;94(8):2177-81. doi: 10.1111/j.1572-0241.1999.01291.x. Am J Gastroenterol. 1999. PMID: 10445546

9

Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis.

Baert F, Wouters K, D'Haens G, Hoang P, Naegels S, D'Heygere F, Holvoet J, Louis E, Devos M, Geboes K. Baert F, et al. Gut. 1999 Sep;45(3):375-81. doi: 10.1136/gut.45.3.375. Gut. 1999. PMID: 10446105 Free PMC article.

10

Crohn's disease and intestinal endometriosis: an intriguing co-existence.

Craninx M, D'Haens G, Cokelaere K, Baert F, Penninckx F, D'Hoore A, Ectors N, Rutgeerts P, Geboes K. Craninx M, et al. Among authors: baert f. Eur J Gastroenterol Hepatol. 2000 Feb;12(2):217-21. doi: 10.1097/00042737-200012020-00014. Eur J Gastroenterol Hepatol. 2000. PMID: 10741938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page